ConMed
CNMD
46.56
+0.18
+0.39%
ConMed
US · CNMD
#3018 by market cap
Listed 1970
46.56
+0.18
+0.39%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $40Market Newswire · 2026/7/13
-
Rating change
Piper Sandler Maintains ConMed(CNMD.US) With Buy Rating, Cuts Target Price to $68Market Newswire · 2025/7/31
-
Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating, Raises Target Price to $49Market Newswire · 2026/10/29
-
Needham Maintains ConMed(CNMD.US) With Hold RatingMarket Newswire · 2026/10/29
-
Rating change
Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Alto Neuroscience, Inc. (ANRO) and Pfizer (PFE)TipRanks · 2026/3/18
-
Rating change
Needham Maintains ConMed(CNMD.US) With Hold Rating, Announces Target Price $35.96Market Newswire · 2026/4/30
-
A Quick Look at Today's Ratings for ConMed(CNMD.US), With a Forecast Between $45 to $46Market Newswire · 2026/7/31
-
Rating change
Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (CGON) and Conmed (CNMD)TipRanks · 2025/12/6
-
J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Raises Target Price to $50Market Newswire · 2026/10/29
-
Rating change
Piper Sandler Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $55Market Newswire · 2026/1/29
-
Rating change
BofA Securities Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $52Market Newswire · 2025/12/8
-
Rating change
J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $40Market Newswire · 2026/4/30
-
Rating change
Piper Sandler Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $39Market Newswire · 2026/4/30
-
Rating change
TR | OpenAI - 4o Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2025/8/12
-
Rating change
J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $52Market Newswire · 2025/11/6
-
Rating change
Piper Sandler Maintains ConMed(CNMD.US) With Buy Rating, Cuts Target Price to $55Market Newswire · 2025/11/6
-
Rating change
Piper Sandler Downgrades ConMed(CNMD.US) to Hold Rating, Cuts Target Price to $39Market Newswire · 2026/3/17
-
Rating change
BofA Securities Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $40Market Newswire · 2026/5/18
-
Rating change
Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $42Market Newswire · 2026/3/18
-
Rating change
Needham Maintains ConMed(CNMD.US) With Buy Rating, Cuts Target Price to $61Market Newswire · 2025/5/2
-
Rating change
Needham Downgrades ConMed(CNMD.US) to Hold RatingMarket Newswire · 2025/6/13
-
Needham Maintains ConMed(CNMD.US) With Hold RatingMarket Newswire · 2026/7/13
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
ConMed discussion 0 comments